Condition: Diabetic Peripheral Neuropathy

This is a phase 2 study evaluating the efficacy and safety of a low and high dose of study LX9211 compared to placebo in patients with moderate to severe diabetic peripheral neuropathy.

Location(s): Jacksonville- LaVilla (Downtown), Lake CIty, Macon

Condition: Diabetic Peripheral Neuropathy